Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
Inorg Chem ; 63(2): 983-999, 2024 Jan 15.
Artigo em Inglês | MEDLINE | ID: mdl-38157417

RESUMO

Two pseudopolymorphic 1D coordination polymers of the formulas [Cd(3,3'-pytz)(CH3OH)2(ClO4)2]n (1) and [Cd(3,3'-pytz)(CH3CN)2(ClO4)2]n (2) have been prepared using the electron-deficient 3,6-bis(pyridin-3-yl)-1,2,4,5-tetrazine (3,3'-pytz) ligand and cadmium perchlorate in the chloroform/methanol and chloroform/acetonitrile solvent system, respectively. It was observed that compounds 1 and 2 experienced one-step (CPreagent → CPproduct) single-crystal-to-powder structural transformation to the pure water-coordinated compound [Cd(3,3'-pytz)(H2O)2(ClO4)2]n (3) by absorbing water vapor from air (solid-gas phase transformation). Interestingly, compounds 1, 2, and 3 undergo a different transformation path and show an in situ unique three-step (CPreagent → CPproduct → Ligandintermediate → CPproduct) single-crystal-to-single-crystal (SCSC) structural transformation process through soaking in deionized water (solid-liquid phase transformation). In this fascinating transformation, we report for the first time the direct conversion of a ligand into a coordination polymer by a rare core-shell pathway in a solid-liquid phase transformation. In this process, we obtained compound {[Cd(3,3'-pytz)(H2O)4](3,3'-pytz)2(ClO4)2(H2O)6}n (4) (single-crystal = S, crystal = C, or microcrystal = P) as mixed compounds of core-shell L@4C and 4S or core-shell L@4P and 4P for compounds (1 and 2) and 3, respectively.

2.
Int J Reprod Biomed ; 21(8): 629-638, 2023 Aug.
Artigo em Inglês | MEDLINE | ID: mdl-37885971

RESUMO

Background: Cyclophosphamide (CP) is an anticancer drug that acts as an alkylation agent after metabolism in the liver. CP has toxic effects on the body's cells, especially the reproductive system's function, and causes infertility. Moreover, medicinal plants have few side effects and are psychologically acceptable to patients. Objective: This study aimed to investigate the impact of Ephedra pachyclada hydroalcoholic extract (EPHE) on ovarian tissue and hypothalamic-pituitary-gonadal axis in rats treated with CP. Materials and Methods: In this experimental study, 48 adult female Wistar rats (180-200 gr, 9-10 wk) were randomly assigned to 6 experimental groups (n = 8/each): (a) control; (b) sham; (c) CP; (d) CP+250 mg/kg EPHE; (e) CP+500 mg/kg EPHE; (f) CP+1000 mg/kg EPHE. On the 29th day of the experiment, serum was collected; serum concentration of the luteinizing hormone, follicle-stimulating hormone, estrogen, progesterone, and antioxidant activity were measured. The number of ovarian follicles were also counted. Results: In the CP groups, serum concentrations of follicle-stimulating hormone and luteinizing hormone significantly increased, and estrogen and progesterone significantly decreased (p ≤ 0.05). EPHE significantly compensated for the complications caused by CP and 1000 mg/kg had the greatest effect. Antioxidant reduction by CP was significantly enhanced by EPHE, especially at higher doses (p ≤ 0.05). The number of primordial, primary, secondary, and Graafian follicles showed a significant decrease in CP groups and EPHE groups showed a significant increase compared to the CP. EPHE showed that the concentration of 1000 mg/kg was more effective than other doses (p ≤ 0.05). Conclusion: In addition to proving the effect of EPHE on the hypothalamic-pituitary-gonadal axis, our investigation showed antioxidant properties, which can be an effective factor in CP-treated rats.

3.
Int J Reprod Biomed ; 21(4): 285-294, 2023 May.
Artigo em Inglês | MEDLINE | ID: mdl-37260555

RESUMO

Background: Cyclophosphamide (CP) has clinical applications in treating diverse malignancies and autoimmune disorders; at the same time, it also has harmful effects on the body tissues, particularly the genitals. The most significant side effects of CP are changing the reproductive system's function and infertility. Objective: This study determines the Ephedra hydroalcoholic extract (EP) role on testicular tissue and the pituitary-gonadal axis in CP-treated male rats. Materials and Methods: In this experimental study, 48 adult Wistar rats were separated into 6 groups (n = 8/each): control, sham, CP recipients, and CP recipients with gavage-fed EP (250, 500, and 1000 mg/kg). On the 29th day, the blood of the weighed animals' was drawn from their heart, and serum concentrations of follicle-stimulating hormone, luteinizing hormone, and testosterone were measured. After preparing testicular tissue segments, cells were counted. Results: While CP decreased follicle-stimulating hormone, luteinizing hormone, and testosterone levels (p < 0.05), the use of EP changed them and even reached the control. Serum gonadotropin-releasing hormone increased significantly in all EP groups compared to the control and CP groups. Compared to the control, a significant decrease in total antioxidant capacity and plasma glutathione peroxidase was observed in the CP groups. EP (all doses) significantly increased their concentration compared to the CP group (p < 0.05); significant reduction in serum total oxidant status and malondialdehyde in CP groups changed by EP (p < 0.05). Although CP's role on spermatogonia counts (57.5 ± 5.2 in CP, 67.1 ± 6.0 in control), higher doses of EP had no significant effect on this but did affect spermatocyte and spermatid cells count. Conclusion: Due to its antioxidant characteristics, EP mitigated the effects of CP on the investigated parameters in rats.

SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...